Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Eli Lilly and Company
Age
10–17
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Participants with Type 2 Diabetes Mellitus (T2DM) for at least 3 months
Have Glycated hemoglobin (HbA1c) level of 6.5 percent (%) to 9.5% at screening
Have a body mass index equal to or less than 45.0 kilograms per square meter (kg/m²)
Participants are insulin naïve or have been without insulin treatment for at least 3 months prior to screening
You may not be if
Have had a severe hypoglycemia in the past 6 months
Have a history of renal impairment
Have had a blood transfusion or severe blood loss within last 90 days
Have had a significant weight gain or loss of approximately 6% or more within 3 months prior to screening.
Have a history of an active or untreated malignancy
Are receiving or received systemic glucocorticoid therapy
Are currently enrolled in another clinical study trial involving medical research or have participated within the last 30 days in a clinical study involving an investigational product
Clareo Health | A Study to Evaluate Pharmacokinetics of LY3209590 in Pediatric Participants With Type 2 Diabetes Mellitus
